Hot Stock of the Year: Zynerba Pharmaceuticals

Zynerba Pharmaceuticals (ZYNE) has been one of the most explosive small-cap stocks of the year. After starting January 2019 at $3, it’s already rocketed to $8.80 a share. And to be honest, there may be further upside ahead thanks to the cannabis story. Just recently, the U.S. FDA announced it would hold its first public … Continue reading "Hot Stock of the Year: Zynerba Pharmaceuticals"
Zynerba Pharmaceuticals (ZYNE) has been one of the most explosive small-cap stocks of the year. After starting January 2019 at $3, it’s already rocketed to $8.80 a share. And to be honest, there may be further upside ahead thanks to the cannabis story. Just recently, the U.S. FDA announced it would hold its first public … Continue reading "Hot Stock of the Year: Zynerba Pharmaceuticals"